Home » BIOSEEK INITIATES COMPOUND EVALUATION COLLABORATION WITH GLAXOSMITHKLINE
BIOSEEK INITIATES COMPOUND EVALUATION COLLABORATION WITH GLAXOSMITHKLINE
BioSeek, Inc., a leader in applying integrated human biology systems for developing new therapeutics, announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK). Under the collaboration, BioSeek will apply its BioMAP Systems for the characterization of compounds from GSK.
Yahoo
News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May